Telegram Web
The Union government's efforts on infrastructure development and investments in critical sectors such as railways, defense, power, and data centers is expected to drive growth momentum into financial year (FY) 2026 and beyond, says a report by financial services firm Prabhudas Lilladher (PL).
India has raised concerns regarding issues faced by its milk exporters in Nepal. In response, Nepal has agreed to consider facilitating the import of specific milk products like whey and cheese that are not adequately produced in Nepal. The two nations also discussed amendments to trade agreements, development of trade infrastructure, and various other trade-related issues.
Stock market recommendations: Motilal Oswal Financial Services Ltd recommends TCS and Coal India Limited for stock investments, highlighting TCS's shift to modernization and cloud initiatives, and Coal India's dominant market position and growth prospects due to increasing power demand and thermal capacity expansions.
Stock market today: BSE Sensex and Nifty50, the Indian equity benchmark indices, crashed in trade on Monday morning. While BSE Sensex went below 76,600, Nifty50 was near 23,200.
China's trade surplus hit a record $992 billion in 2024, driven by a 21% rise in exports worth $3.6 trillion, despite weak domestic demand and imports. The surge is linked to strong overseas demand and anticipated tariffs under Donald Trump's upcoming presidency, leading to a rush in shipments to the US, reaching $525 billion.
Aragen secures $100 million funding from Quadria Capital
https://timesofindia.indiatimes.com/business/india-business/aragen-secures-100-million-funding-from-quadria-capital/articleshow/117198160.cms

Aragen Life Science, formerly GVK Biosciences, secures a $100 million investment from healthcare-focused private equity fund Quadria Capital. The investment will support Aragen’s strategic expansion and infrastructure development to meet growing demand for outsourcing services from US and Europe innovators. This move positions Aragen strongly in the pharmaceutical outsourcing market, enhancing its capabilities and accelerating program delivery.
2025/07/13 16:37:42
Back to Top
HTML Embed Code: